GlassScriptPhysician profile
Heather J Black
NPI 1235788696
$16,460.90
in general payments reported to CMS, 2019-2025
43 companies · $6,292 in 2025
The $6,292 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,777 · 2022: $2,173 · 2023: $1,725 · 2024: $4,495 · 2025: $6,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,316 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,280 · Travel and Lodging: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,316.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,280.00 |
| Travel and Lodging | $914.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $8,837.08 | 2021-2025 | Nayzilam, Briviact, Fintepla |
| Abbvie INC. | $1,565.49 | 2021-2025 | |
| Neurelis, INC. | $1,091.72 | 2021-2025 | Valtoco |
| Sk Life Science, INC. | $836.27 | 2021-2025 | |
| Lilly USA, LLC | $377.92 | 2021-2024 | Emgality, Reyvow, Amyvid |
| Amgen INC. | $372.15 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $344.49 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $292.10 | 2021-2024 | Austedo Xr, Austedo, Ajovy |
| Pfizer INC. | $247.84 | 2023-2025 | |
| Lundbeck LLC | $242.22 | 2022-2025 | Vyepti |
| Aucta Pharmaceuticals, INC. | $225.68 | 2024-2025 | Motpoly Xr |
| Axsome Therapeutics, INC. | $223.47 | 2025 | Symbravo |
| Aquestive Therapeutics, INC. | $203.14 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $166.92 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $150.84 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.